Compass Therapeutics, Inc.: Form SC 13D/A, filed Nov 9, 2021
Filed with the SEC on Nov 9, 2021 and accepted by EDGAR at Nov 9, 2021, 22:30 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000947871-21-001157. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.